Ordering The Autoimmune Brain Panel™Uncover the Root Cause
Looking beneath the surface to bring you answers.
Still struggling with symptoms like anxiety, depression, OCD, tics or mood changes — despite treatment? The Autoimmune Brain Panel™ may provide some answers. This advanced blood test can help identify whether your symptoms may be due to an underlying immune dysfunction, triggered by infection – rather than a primary neurologic or psychiatric disorder.
One simple blood draw – ordered by your provider – may put you on the path to recovery.
Don’t have a provider? Let us help you find one.
Are you looking for a clinician to order the Autoimmune Brain Panel™? We can help!
Please complete the form below and our Medical Relations Manager, Amy Cross, RN PMHNP, will be in touch to provide several options.
Live in New York? International?
The Autoimmune Brain Panel™ requires a clinician order before we can receive and process any specimen. Moleculera Biosciences can accept clinician test orders from all 50 states in the U.S. and other countries. Practitioners in New York State may order the Autoimmune Brain Panel™ but specimens must be collected at a facility outside the State of New York.
Patients living outside the United States, can order the test through one of our international partners. Please visit our international ordering page.
We know advanced testing can feel out of reach. The Autoimmune Brain Panel™ is a comprehensive diagnostic test valued at $995, but most patients do not pay the full amount. With our support, your cost is typically $495 out-of-pocket, and many patients are reimbursed by their insurance for part or all of the remaining balance. In fact, about 60% of patients receive additional coverage through their insurance plan.
The Autoimmune Brain Panel™ requires a clinician order before we can receive and process any specimen. Moleculera Biosciences can accept clinician test orders from all 50 states in the U.S. and other countries. Practitioners in New York State may order the Autoimmune Brain Panel™ but specimens must be collected at a facility outside the State of New York. Patients residing outside the U.S., please see our International Ordering Page.
- In the continental United States, the cost for the Panel is $995.
- In Alaska, Hawaii, and Canada, the cost for the Panel is $1070 (USD).
- Payment plans are available.
- We accept checks, credit cards, FSA and HSA.
Insurance is filed once the test report has been released. The date of service used to file the insurance is the date the specimen was collected.
Approximately 50% of patients receive some level of reimbursement.
Results That Guide Treatment
Your results aren’t just numbers — they’re a roadmap.
The Autoimmune Brain Panel™ helps determine whether your neuropsychiatric symptoms may be due to an infection-triggered autoimmune dysfunction. Test results assist clinicians in selecting treatments that address the underlying infectious and immune-related root cause.
Once identified and treated properly, patients frequently report a complete resolution or substantial reduction in their symptoms.
Neuropsychiatric Symptoms and Test Biomarkers
Anti-Dopamine D1 Receptor Antibodies
Individuals with elevated levels of autoantibodies against Dopamine D1 receptor typically experienced psychiatric symptoms, including psychosis.
Anti-Dopamine D2 Receptor Antibodies
Individuals with elevated levels of autoantibodies against Dopamine D2 receptor typically experienced movement disorders and impulsivity.
Anti-Lysoganglioside GM1 Antibodies
Individuals with elevated levels of autoantibodies against Lysoganglioside GM1 typically experienced neuropathic symptoms, including tics.
Anti-Tubulin Antibodies
Individuals with elevated levels of autoantibodies against Tubulin typically experienced cognitive complaints, OCD and brain fog.
CaMKII – A Cell Stimulation Assay
Individuals with elevated CaMKII levels were often positive with involuntary movements and any symptom of adrenergic activation.
An elevated CaMKII result indicates a patient’s autoantibodies are stimulating this enzyme. CaMKII is responsible for upregulating brain neurotransmitters such as dopamine, epinephrine and norepinephrine.
CaMKII activation may result in disrupted neuronal functioning, and trigger a variety of neurologic and/or psychiatric symptoms.